30976. Alleged adulteration and misbranding of Adrenapit (solution epinephrine chloride 1:1000), solution of pituitary extract, and suprarenals. V. S. v. Harvey-Pittenger Co. Tried to the court -without a jury. Judgment of not guilty. (F. & D. No. 3973T. Sample Nos. 8226-C to 8229-C, incl.) Action was instituted in this case on the charge that the products failed to conform to the standard established by the United States Pharmacopoeia or by the National Formulary, and that their potency was below that declared on the labels. On July 22, 1937, the United States attorney for the Eastern District of Pennsylvania, acting upon a report by the Secretary of Agriculture, filed in the district court an information against the Harvey-Pittenger Co., a corporation, Philadelphia, Pa., alleging shipment by said company in violation of the Food and Drugs Act on or about August 4,1936, from the State of Pennsylvania into the State of North Carolina, of quantities of the above-named drugs which were adulterated and misbranded. The Adrenapit (solution epinephrine chloride 1:1000) was alleged to be adulterated in that it was sold under and by a name recognized in the United States Pharmacopoeia but differed from the standard of strength, quality, and purity as determined by the test laid down in the pharmacopoeia official at the time of investigation in that it contained not more than 67 percent of the potency required for solution of epinephrine hydrochloride prescribed in the pharmacopoeia and its standard of strength, quality, and purity was not declared on the container. It was alleged to be adulterated further in that its strength and purity fell below the professed standard of strength and quality under which it was sold in that it was represented to be solution of epinephrine chloride 1:1000; whereas it was not solution epinephrine chloride of the potency 1:1000. It was alleged to be misbranded in that the statements (carton and bottle), "Solution Epinephrin Chloride 1:1000 Physiologically Standardized. A * * * physiologically standardized solution of the isolated blood-pressure-raising principle of the suprarenal glands. Adrenapit is * * * A Potent, Uniform, Dependable Preparation," (booklet) "(Solution Epinephrine Chloride 1:1000) A * * * Potent, Uniform Dependable Standardized solu- tion of the blood-pressure-raising principle of the Suprarenal Gland * * * Adrenapit * * * Is a * * * solution of the isolated blood-pressure- raising principle of the suprarenal glands. * * * It is adjusted to a definite physiologic activity by its quantitative effect on the blood pressure of dogs as compared with a standard. * * * A potent, Uniform, Dependable, Prepara- tion. * * * it is of definite strength," were false and misleading since the article was not a solution of epinephrine chloride of strength 1:10CO, it was not physiologically standardized; it was not a physiologically standardized solution of the isolated blood-pressure-raising principle of the suprarenal glands, it was not a potent, uniform, dependable preparation, and it was not of definite strength, in that it was a preparation materially deficient in potency. The solution of pituitary extract was alleged to be adulterated in that it was sold under a name recognized in the United States Pharmacopoeia but differed from the standard of strength, quality, and purity as determined by the tests laid down in the said pharmacopoeia in that 1 cubic centimeter of the article produced an activity upon the isolated uterus of the virgin guinea pig corresponding to less than 80 percent of that produced by 0.005 gram of the standard powdered posterior pituitary, namely, an activity cor- responding to 45 percent of that produced by 0.005 gram of the standard powdered posterior pituitary; whereas the pharmacopoeia provides that 1 cc. of solution pituitary extract shall produce an activity upon the isolated uterus of the virgin guinea pig corresponding to not less than 80 percent of that pro- duced by 0.005 gram of standard powdered posterior pituitary. It was alleged to be misbranded in that the statements (carton and bottle), "Solution of Pitu- itary Extract. A * * * solution of the extract of the posterior lobe of the Pituitary Gland * * * Physiologically Standardized," and (carton only) "Specify Harvey-Pittenger * * * Highest Potency * * * Including * * * Physiologically Standardized * * * Endocrine Substances," were false and misleading in that the article was not solution of pituitary extract; was not a solution of the extract of the posterior lobe of the pituitary gland, was not physiologically standardized, was not of the highest potency, and did not include physiologically standardized endocrine substances, in that the article was a preparation materially deficient in potency. The suprarenals were alleged to be adulterated in that they were sold under a name recognized in the National Formulary but differed from the standard of strength, quality, and purity as determined by the test laid down in said formulary in that they yielded less than 0.8 percent of epinephrine, namely, 0.5 percent of epinephrine, equivalent to 5 milligrams in 1 gram of the article; whereas the National Formulary provides that suprarenal shall yield not less than 0.8 percent of natural epinephrine of glandular origin. They were alleged to be misbranded in that the statements, (carton and bottle) "Suprarenals Desiccated. One part represents about six parts of fresh glands. Physiologi- cally Standardized so that 1 gm. contains the equivalent of 10 mgm. Epinephrin" and "Uniform * * * preparations are assured by the appli- cation of every known chemical and biological method of Standardization," (carton) "Specify Harvey-Pittenger * * * Highest-Potency * * * In- cluding * * * Physiologically Standardized * * * Endocrine Sub- stances," were false and misleading in that the article was not suprarenals desiccated, one part thereof did not represent six parts of fresh glands, it was not physiologically standardized so that 1 gram contained the equivalent of 10 milligrams of epinephrine, it was not standardized by every known chemical and biological method, it was not of the highest potency and did not include physiologically standardized endocrine substances, and in that it was a prepa- ration materially deficient in potency. On December 18, 1939, a plea of not guilty having been entered on behalf of the defendant and a jury having been waived, the case came on for trial before the court. Evidence was introduced on behalf of the Government and of the defendant, at the conclusion of which the court entered a judgment of not guilty. GROVER B. HILL, Acting Secretary of Agriculture.